Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.
Berardino De BariAlessandra Franzetti-PellandaAsma SaidiMaira BiggiogeroDieter HahnloserMichael MontemurroJean BourhisMichele ZeverinoMahmut OzsahinPublished in: Journal of cancer research and clinical oncology (2019)
Neoadjuvant chemoradiotherapy delivered with HT under daily image guidance is well tolerated and shows a high 4-year local control rates.